With more than 65 clinical trials underway to test
immunotherapy’s effectiveness in treating blood
cancers, MD Anderson is a leader in the field
Summer 2017 : Cancer Frontline
MD Anderson again is named the nation’s top cancer hospital
MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey. Since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals, and it has ranked first 13 times in the past 16 years.
“To consistently be recognized for the quality and compassionate cancer care we provide patients who come to MD Anderson seeking our innovative approaches, world-renowned expertise and decades of experience is a true honor,” says Marshall Hicks, M.D., president ad interim.
Two MD Anderson subspecialties also received high rankings in the survey. In the Ear, Nose and Throat specialty, the institution’s Head and Neck Surgery service was No. 15, while Gynecologic Oncology and Reproductive Medicine came in No. 17 in the Gynecology category. The survey also ranked MD Anderson as “High Performing” in Diabetes & Endocrinology, Orthopedics and Urology.
MD Anderson’s commitment to patients and its mission to end cancer have driven the institution for more than 75 years and continue to fuel its efforts to improve the level of cancer care all over the world. Serving nearly 135,000 patients last year in the Texas Medical Center and throughout the Houston region, MD Anderson also extends its standard of care by collaborating with community hospitals and health systems around the world. Combined with other initiatives in prevention, research and education, MD Anderson’s outreach enables millions of local, domestic and international patients to have greater access to its expertise, experience and innovation.
“This recognition from U.S. News & World Report is a reminder that patients are at the center of all we do now and all we envision for the future,” says Stephen Hahn, M.D., deputy president and chief operating officer. “Our mission is bold, but it’s through innovative care, research, education and prevention that we will fulfill our promise to end cancer. It’s what we strive for every day.”
Read about the latest progress in Making Cancer History® in the Cancer Frontline blog.
More Stories From Conquest
Second opinions and second chances
Maybe it was Antonia Shiffman’s background in nursing, or her natural inclination to get to the bottom of things that spurred her to seek a second opinion from MD Anderson.
High risk runs in their family
This genetic syndrome greatly increases the chances
of developing several cancers, but those who know they have it can catch the disease early, before it’s too late
To treat or not to treat
Active surveillance may be a better choice for some men with prostate cancer
Progress against pancreatic cancer is measured in laps around the mall
With a shift toward routine presurgical treatment
and steady improvements in imaging, surgery,
radiation, chemotherapy and other specialties,
doctors at MD Anderson have greatly improved
care for pancreatic cancer patients. And they’re
continuing to further those advances.
